Aetna Reports Revenue Up As Medicare, Medicaid Plans Perform Well
But the insurer lowered its forecast because of membership declines in commercial policies and losses from its business on the health law marketplaces.
The independent source for health policy research, polling, and news.
35,681 - 35,700 of 112,572 Results
But the insurer lowered its forecast because of membership declines in commercial policies and losses from its business on the health law marketplaces.
Treating chronic diseases accounts for 86 percent of the nation's health care spending so the senators' efforts to make Medicare policy more efficient could help both the patient and the budget. Also, federal officials are temporarily blocking more insurers from automatically switching customers to Medicare.
“There is no justification for moving forward with legislation that provides substantial benefits to the drug industry without asking for something in return," liberal groups wrote to the House Energy and Commerce Committee. It's unlikely, though, that Republicans would agree to such additions.
In other pharma news: what would a big election win for Democrats mean for the biotech industry; a Cuban lung-cancer vaccine gets its first U.S. clinical trial; and AstraZeneca halts enrollment into two trials for a head and neck-cancer treatment while it investigates bleeding in some patients.
The Defense Department gets a discount on EpiPens dispensed at military treatment facilities and by mail order, but nearly half of its spending was at retail pharmacies where it most recently paid an average of $509 for EpiPen and $528 for EpiPen Jr two-packs. In total, the Pentagon paid about $54 million more than it should have from 2009 to 2016.
The candidate's suggestions to improve the health law are anathema to congressional Republicans.
Minnesota Gov. Mark Dayton proposes a state-funded rebate to help offset the spiking premiums facing the state's residents. Media outlets also report on developments in Maryland, Connecticut and California.
Subsidies provide a safety net for most customers, but there's not a backup plan if insurers completely pulling out of the marketplace. Meanwhile, President Barack Obama paints a sunny picture of his signature law in the face of negative news about the premiums.
Today's early morning highlights from the major news organizations.
A selection of opinions on the Affordable Care Act from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Outlets report on health news from Georgia, Pennsylvania, Vermont, Illinois, Ohio, Massachusetts, Florida, Arizona and California.
Neighborhood Health Plan, a subsidiary of Partners HealthCare, has lost $241 million since 2014. Meanwhile, a new study in Maryland finds that the Medicaid program spends twice as much on enrollees with diabetes than those who don't have the condition.
Media outlets also report on cancer-causing heavy metal and tumors that grow on fetuses in the womb.
The experiment will take place in cities in Brazil and Colombia over two to three years. Also, the head of the Centers for Disease Control and Prevention says the Zika virus is in the U.S. to stay.
New genomic sequencing research shows that the virus has been in America a lot longer than previously thought.
Three years after an investigation exposed a dramatic rise in the number of opiate prescriptions at the agency, it has reduced the number by nearly 25 percent.
Alvin Young's nickname is Dr. Orange and he thinks veterans who complain about sickness that they think is related to a toxic herbicide used in the Vietnam War are simply “freeloaders,” making up ailments to “cash in” on the VA’s compensation system. And he's also the one expert the military relies on to decide whether to compensate veterans.
Up to 700 doctors are expected to leave Puerto Rico this year alone, double the number from two years ago.
Meanwhile, in California, Bernie Sanders rallies for Proposition 61, a ballot initiative that would place some limits on prescription drug prices. And pharmacy benefit manager Express Scripts' dealings with pharmaceutical companies are under scrutiny by federal investigators.
© 2026 KFF